BSEBoard Meeting6d ago · 24 Aug 2026, 06:10 pm
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 ,inter alia, to consider and approve (i)discussion and consideration ....
Wardwizard Healthcare Ltd · 512063
✦ AI SummaryFundraise
Wardwizard Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 31/08/2026 to consider and approve proposal for raising further capital, increase in authorized share capital, and consequential alteration of the capital clause.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Wardwizard Healthcare Ltd - 512063 - Board Meeting Intimation for Discussion And Consideration Of Proposal For Raising Further Capital And Any Other Business As Per Details Attach Herewith
Attachments (1)
📄pdf
Download →
ad36ffa7-a41e-4889-a602-1758e8717221.pdf
View document text
Date: 24 /08/2026 Ref: WHL/BSE/BM-INTIMATION-3 /2026-27
BSE Limited
Kind Attn.: Corporate Relations Department
Corporate Relations Department
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai-400 001
Ref: - Wardwizard Healthcare Limited (BSE Script code: 512063)
Subject: Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam,
Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations
2015, as amended from time to time, we hereby inform you that a Meeting of the Board of Directors
of the Company has been scheduled to be held on Monday, 31th Day of August, 2026 to inter-alia
transact the following business:
(i) To discuss and consider proposal for raising further capital and to create, offer, issue and
allot such number of equity shares and equity linked instruments or securities, including
convertible preference shares, non-convertible debt instruments along with warrants, fully
convertible debentures, partly convertible debentures, and/or any other securities
convertible into equity shares (including warrants or otherwise), Global Depository Receipts,
American Depository Receipts, Foreign Currency Convertible Bonds, through public and/or
private offerings and/or by way of qualified institutional placement, and / or preferential
allotment and / or through any other permissible mode in accordance with the relevant
provisions of applicable law or any combination thereof, in accordance with the Securities
and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations,
2018, as amended, and all other applicable laws, as may be considered appropriate, subject
to such governmental/ statutory/regulatory and other approvals as may be required
including the approval of the shareholders of the Company in the ensuing General Meeting.
(ii) Increase in the Authorized Share Capital of the Company and Consequential Alteration of the
Capital Clause (Clause V) of the Memorandum of Association.
(iii) Any other matter with permission of the Chair
We further wish to inform you that in terms of the provision of the Securities and Exchange Board of
India (Prohibition of Insider Trading) Regulations, 2015, as amended, and the Company’s Code of Fair
Disclosure and Code of Conduct for Prevention of Insider Trading, the trading window for dealing in
securities of the Company, will be closed from 24th August, 2026, for all the Designated / Connected
persons and their immediate relatives till 48 hours after the announcement of outcome of the Board
Meeting
Kindly take note of the same in your records.
Thanking you,
For WARDWIZARD HEALTHCARE LIMITED
RAJBALA KIRORIWAL
Company Secretary and Compliance Officer
Membership no. A51986